Status:
COMPLETED
A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease
Lead Sponsor:
Allergan
Conditions:
Dry Eye Syndromes
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study will evaluate the safety and efficacy o fRefresh Optive® Gel Drops in patients with dry eye disease.
Eligibility Criteria
Inclusion
- Current use of an artificial tear product
- Visual acuity of at least 20/32 (while wearing glasses, if necessary).
Exclusion
- Use of contact lenses in the last 3 months, or anticipated use of contact lenses during the study
- Cataract surgery, laser-assisted in situ keratomileusis \[LASIK\], or photorefractive keratectomy, within the last 6 months
- Current eye infection or inflammation
Key Trial Info
Start Date :
November 13 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 16 2015
Estimated Enrollment :
188 Patients enrolled
Trial Details
Trial ID
NCT02280473
Start Date
November 13 2014
End Date
March 16 2015
Last Update
April 16 2019
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
North Bay Eye Associates
Petaluma, California, United States, 94954
2
Eric M. White, OD, Inc.
San Diego, California, United States, 92123
3
Eye Center Northeast
Bangor, Maine, United States, 04401
4
Moyes Eye Center, PC
Kansas City, Missouri, United States, 64154